La Merie Biologics is published each Monday and sent by e-mail. This weekly newsletter is focused on antibodies, proteins & peptides, gene therapy, RNA and cell therapy, vaccines, biosimilars and related business regarding licensing, collaborations and M&A. It contains a list with the titles of press releases of the previous week with embedded hyperlinks leading to the full length press releases posted on our website.
Subscribers to La Merie Biologics agree to occasionally receive commercial information about products from La Merie Publishing.
You can Unsubscribe at any time from our newsletters by clicking on the Unsubscribe button at the bottom of the newsletters or by contacting us via e-mail, fax, phone or letter as indicated in the newsletter and the Contact Us menu of our homepage www.pipelinereview.com
La Merie will never sell, rent or loan your e-mail address to any other organization.
Read Whitelist Instructions